+44 203 371 1100
+44 203 371 1100
Credit Sector:- Health Care
Country:- United States
Bond Document:- https://www.bondpdf.com
In order to view the complete data, please login here
| Announcement Date | CA Type | CA Impact | CA Event | ISIN |
|---|---|---|---|---|
| 18-Sep-2023 | Propose Spin Off | Target Name | Pelican Technology Holdings, Inc. | US00214WAE12 |
| Ligand Pharmaceuticals Incorporated has announced that it intends to spin-off Pelican Technology Holdings, Inc. | ||||
| 17-Jul-2023 | Propose Asset Acquisition | - | - | - |
| Ligand Pharmaceuticals Incorporated today announced that it intends to acquire () from (). | ||||
| 27-Sep-2023 | Asset Acquisition | - | - | - |
| Ligand Pharmaceuticals Incorporated today announced that it has acquired assets of Novan, Inc.. | ||||
| 01-Nov-2023 | Acquisition | Acquired Name | Tolerance Therapeutics, Inc. | - |
| Ligand Pharmaceuticals Incorporated today announces that it has acquired Tolerance Therapeutics, Inc.. | ||||
| 08-Jul-2024 | Propose Acquisition | Target Name | Apeiron Biologics AG | - |
| Ligand Pharmaceuticals Incorporated today announced that it intends to acquire Apeiron Biologics AG. | ||||
All of the financial data available on this page is sourced from FactEntry.